Comprehensive range of early stage drug discovery services to Pharma, Biotech and Academia. Our services are forward integrated with our API and formulation offerings, covering the entire drug value chain.
Clinical development services from Phase I to Phase III for various dosage form such as Oral solids, liquids, creams, ointments, and sterile injectable. Our integrated offerings accelerate the time to market and reduce costs for our customers.
Piramal offers contract manufacturing for API, HPAPI and a wide variety of dosage forms. We offer our solutions through a network of facilities located across North America, Europe and Asia.
ANTIBODY DRUG CONJUGATION
Piramal is the global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies.
Piramal’s Generic API division offers an indigenous basket of off-patent APIs for global markets.
Committed to Excellence
History, Ingenuity & Excellence: The Story Of ADC Development At Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) maintains its position as an internationa...
The importance of Data Analysis in Solid-State Characterisation
Performing solid-state characterization involves integrating a large amo...
Integrated Services: Partnerships For Success
Efficiency, speed-to-market, and access to unique expertise are among th...
Big Pharma, Europe
Big Pharma, US
Generic Pharma, India
NEWS for you
Peter DeYoung, CEO, Piramal Global Pharma in conversation with Chemicals Knowledge Hub TV
Jun 06, 2020
Peter DeYoung, CEO, Piramal Global Pharma interacts with Global Business Report on US Biopharmaceuticals 2020
May 05, 2020
READY TO DEVELOP A SUCCESSFUL PARTNERSHIP?
We will work together to create the right solution for you